Enfermedad de Wilson rápidamente evolutiva y con presentación inusual / Wilson’s disease with unusual presentation and rapid evolution

Presentamos el caso de un paciente con enfermedad de Wilson que tuvo un comportamiento poco habitual. Previoa la aparición de las manifestaciones neurológicas, tuvo tos como único síntoma, sospechándose una discinesiarespiratoria como forma de presentación. La forma clínica de su enfermedad fue de tipo neurológico puro y sin evidencias de compromiso hepático. No hubo una respuesta satisfactoria al tratamiento instituido y la evolución fue rápida y fatal en poco tiempo.

We present a case of Wilson’s disease with an unusual course. Before the onset of neurological manifestations, cough was the only symptom, suggesting a respiratory dyskinesia as the form of presentation. The disease took a purely neurological type, without signs of hepatic compromise. There was no response to medical treatment, and the evolution was rapid and fatal.

Identification of ATTM as a novel H2 S donor and investigation of its pro-tective effect on HaCaT skin cells / 中国病理生理杂志

AIM:To investigate the ability of a metal complex ammonium tetrathiomolybdate (ATTM) to re-lease H2 S and its cytoprotective effect on an oxidative injury model .METHODS:Released H2 S was absorbed in a reaction flask from ATTM dissolved in the cell medium .Staining with dichlorodihydrofluorescein diacetate or rhodamine 123 fol-lowed by photofluorography was conducted for the observation of reactive oxygen species ( ROS) and mitochondrial mem-brane potential (ΔΨm) levels, respectively.Cell viability and release of lactate dehydrogenase (LDH) from the cells were measured with commercial kits.RESULTS:Similar to another H2S donor GYY4137, ATTM had an ability to release H2S in the cell medium in a dose-dependent manner .Treatment of human skin HaCaT cells with ATTM at concentrations of 25~400 μmol/L didn’ t significantly alter cell viability .Exposure of the cells to ultraviolet rays or a ROS donor H 2 O2 in-creased the intracellular ROS levels .Treatment with 400 μmol/L H2 O2 significantly reduced the viability of HaCaT cells (P<0.01).However, before the treatment with H2O2, pretreatment with ATTM at 100 and 200 μmol/L markedly pre-vented the H2O2-induced cell injury (P<0.01).In addition, the treatment with H2O2 triggeredΔΨm loss (P<0.01) and LDH release from the cells (P<0.01).Prior to suffering from H2O2 injury, the preconditioning with 200 μmol/L ATTM significantly improved ΔΨm levels ( P<0.05 ) and attenuated LDH release from the cells ( P<0.01 ) .CONCLUSION:ATTM is capable of releasing H 2 S and protecting human skin cells against oxidative injury .